focus -WSS

focus

author：focus 2025-08-12 09:13:36 - browse：263

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

WSS

Researchers test human milk's ability to repair gut microbiome

Oral obesity drug from Viking Therapeutics hits key early target

How a Boston hospital is priming medical residents to use GPT

Trial using CRISPR to edit HIV out of cells disappoints

Republican states more likely to report Covid vaccine side effects

Sanders wants to replace patents with prizes for drug inventions

hotspot

focus

explore

Apple is now the first public company to be valued at $3 trillion

Insurer loopholes limit power of law against surprise medical bills

At least 13 dead in Texas as scorching temps continue

Republican states more likely to report Covid vaccine side effects

Hollywood unions extend contract negotiations for actors

Four alarming medical procedures we’re glad history forgot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Continuity nursing helped my family in our darkest PICU moments

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

focus

Scientists uncover potential path to treating deadly childhood tumor

Scientists grapple with ethics of stem cell research

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Scientists grapple with ethics of stem cell research

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Bird flu in dairy cattle: New measures to control spread to humans

focus

focus

knowledge

leisure time